8-KShareholder Matters

QUEST DIAGNOSTICS INC 8-K Report, Shareholder Vote Results (May 21, 2020)

Filed May 21, 2020For Securities:DGX

Summary

This 8-K filing from Quest Diagnostics Inc. (DGX) reports the voting results from its 2020 Annual Meeting of Stockholders held on May 19, 2020. The primary focus is on the outcome of director elections, executive compensation approval, and the ratification of the independent registered public accounting firm. The results indicate strong support from shareholders on these key governance matters. All director nominees were elected, demonstrating shareholder confidence in the current board leadership. Furthermore, shareholders approved the executive compensation as disclosed in the proxy statement, and overwhelmingly ratified the appointment of the company's independent auditors for the fiscal year 2020. This filing provides transparency on how shareholders are exercising their voting rights on critical corporate decisions.

Key Highlights

  • 1All incumbent director nominees were re-elected to the Board of Directors with substantial support.
  • 2The advisory resolution to approve the executive compensation was passed, indicating shareholder agreement with the company's compensation practices.
  • 3The appointment of the independent registered public accounting firm for 2020 was ratified with a significant majority of votes in favor.
  • 4Vicky B. Gregg and Wright L. Lassiter, III received particularly high 'For' votes in their director elections.
  • 5Broker non-votes were present for all director elections and the executive compensation vote, a common occurrence in such meetings.
  • 6The voting results suggest broad shareholder alignment on key governance issues at the 2020 Annual Meeting.

Frequently Asked Questions

Yes, all director nominees presented at the 2020 Annual Meeting of Stockholders were elected by the shareholders for terms expiring at the 2021 Annual Meeting of Stockholders.

Yes, the advisory resolution to approve the executive officer compensation, as disclosed in the Company's 2020 Proxy Statement, was approved by the shareholders.

Yes, the ratification of the appointment of Quest Diagnostics Inc.'s independent registered public accounting firm for 2020 was approved by a substantial majority of the votes cast.

A 'Broker Non-Vote' occurs when a broker holding shares on behalf of a client does not vote on a particular proposal because the client has not provided voting instructions. These non-votes are not counted as 'for' or 'against' a proposal.